Spanish Industry Calls For Dedicated Orphan Drug Reimbursement Route
The current system means Spain is not a priority launch country.
You may also be interested in...
EU stimulus funding marks opportunity to establish health technology appraisal agency in Spain.
Germany’s Confidential Pricing Move Could Protect Companies From Potential Trumpian US Reference Pricing
Confidential pricing would give companies more flexibility to negotiate discounts and prevent withdrawals.
In spite of successfully appealing against previous negative guidance, Pfizer has again failed to secure a positive recommendation from England’s health technology appraisal institute for Oxbryta for hemolytic anemia caused by sickle cell disease, and has been asked to provide more evidence.